| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/06/2007 | US7173137 Epothilone analogs |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173129 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 02/06/2007 | US7173128 Benzoxazinone, oxanilide, benzylidene malonate, quinazoline and benzotriazole derivatives; polymer and photographic stabilizers |
| 02/06/2007 | US7173125 Triphosphate oligonucleotide modification reagents and uses thereof |
| 02/06/2007 | US7173122 Antisense oligonucleotides to type I procollagen |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173102 Facially amphiphilic polymers as anti-infective agents |
| 02/06/2007 | US7173064 Increasing muscle mass and CD4+ lymphocyte levels in HIV-infected individuals |
| 02/06/2007 | US7173063 Induces DNA double-strand breaks without inducing DNA damage; colorectal carcinoma, ovarian cancer, small cell lung cancer and non-Hodgkin's lymphoma |
| 02/06/2007 | US7173062 Method for the improvement of skin wrinkles using retinyl retinoate |
| 02/06/2007 | US7173061 For diagnosis or in vivo imaging of Amyloid-associated diseases such as diabetes; radiolabelled |
| 02/06/2007 | US7173060 Antitumor agents, anticarcinogenic agents; inhibitors of histone deacetylase; a methyleneaminooxymethyl)-thiophene-2-carboxylic acid (2-amino-phenyl)-amide derivatives; chemical synthesis |
| 02/06/2007 | US7173059 Optically active 3-amino-butene and 1,2-dihydroxy-3-amino-butane intermediate compounds |
| 02/06/2007 | US7173058 For inhibiting PDE4(phosphodiesteases) in a mammal; of modulating the production of TNF- alpha; inhibiting matrix metalloproteinases, for therapy of undesired angiogenesis; therapy of cancer |
| 02/06/2007 | US7173057 Compounds as enzyme inhibitors to treat hepatitis with viricides |
| 02/06/2007 | US7173056 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 02/06/2007 | US7173054 Respiratory syncytial virus replication inhibitors |
| 02/06/2007 | US7173053 effective against the growing number of resistant bacteria, particularly the vancomycin resistant enterococci and beta -lactam antibiotic-resistant bacteria, such as methicillin-resistant Staphylococcus aureus |
| 02/06/2007 | US7173052 Resorcinol for lightening skin removing color |
| 02/06/2007 | US7173051 Inhibitors of cathepsin S |
| 02/06/2007 | US7173048 Indolyl derivatives as liver-X-receptor (LXR) modulators |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173046 CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications |
| 02/06/2007 | US7173045 Drugs for forming medicines such as analgesics formed by oximation and basification |
| 02/06/2007 | US7173044 Imidazoline derivatives having CB1-antagonistic activity |
| 02/06/2007 | US7173043 Heteroaromate OSC inhibitors |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173041 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173039 Compounds that modulate or inhibit enzymes for occular diseases |
| 02/06/2007 | US7173038 Treatment of diseases such as cancer or arthritis |
| 02/06/2007 | US7173037 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 02/06/2007 | US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/06/2007 | US7173034 Drugs for treatment of viral diseases such as Respiratory syncytial virus |
| 02/06/2007 | US7173033 Nitrogen-containing heterocyclic compound |
| 02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 02/06/2007 | US7173031 Pyrrolotriazine kinase inhibitors |
| 02/06/2007 | US7173030 administering oxidoreductase inhibitors such as 4-nitro-N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzenesulfonamide, as wound healing agents or for the treatment of diseases or disorders, selected from diabetes, obesity, glaucoma, hyperlipidemia, hyperglycemia, hypertension, osteoporosis, and depression |
| 02/06/2007 | US7173029 Fused heteroaryl derivatives |
| 02/06/2007 | US7173028 Pyrimidine derivatives |
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7173026 Pyrrolo [2,1-c][1,4]benzodiazepine-anthraquinone conjugates useful as antitumour agents |
| 02/06/2007 | US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors |
| 02/06/2007 | US7173024 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
| 02/06/2007 | US7173023 Novel benzazepine derivatives as enzyme inhibitors of monoamine oxidase for disease treatment |
| 02/06/2007 | US7173022 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides |
| 02/06/2007 | US7173021 Anticancer agents, prodrugs for treatment on skins and basification |
| 02/06/2007 | US7173020 Anticancer agents and drug delivery agents with nucleotides |
| 02/06/2007 | US7173019 Linked cyclitols and their polysulfated derivatives |
| 02/06/2007 | US7173018 Antiinflammatory agents; antiischemic agents; antiarthritic agents; antihistamines; multiple sclerosis; Alzheimer's disease; Huntington's disease; parkinson's disease; antiepileptic agents; headaches |
| 02/06/2007 | US7173017 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 02/06/2007 | US7173016 Composition and method for treating graft-versus-host disease |
| 02/06/2007 | US7173014 For therapy of HIV infection |
| 02/06/2007 | US7173009 Surfactant protein C esters |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172884 new strains of Sorangium cellulosum obtained by mutagenesis for the production of epothilones |
| 02/06/2007 | US7172870 Treatment of papillomavirus infections |
| 02/06/2007 | US7172867 Methods of testing for allergic diseases, and therapeutic agents for treating same |
| 02/06/2007 | US7172778 isomers of reduced folate selected from (6S)-tetrahydrofolic acid, 5-methyl-(6S)-tetrahydrofolic acid, 5-formyl-(6S)-tetrahydrofolic acid, 10-formyl-(6R)-tetrahydrofolic acid, 5,10-methylene-(6R)-tetrahydrofolic acid, 5,10-methenyl-(6R)-tetrahydrofolic acid; vitamin B6; birth defect prevention |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | US7172767 Opioid agonist / antagonist combinations |
| 02/06/2007 | US7172761 Polyvalent immunogen |
| 02/06/2007 | US7172756 Methods of promoting tolerogenic immune responses and compositions therefor |
| 02/06/2007 | US7172755 Process control; metastasis; polypeptides |
| 02/06/2007 | US7172754 Cosmetic emulsions with sunscreens and conjugated linoleic acid |
| 02/06/2007 | US7172753 Mixture of triazine, dibenzoylmethane and diarylbutadiene compound |
| 02/06/2007 | US7172752 Synergistic mixture of antiserotonine agents and glucocorticoids; inhalation |
| 02/06/2007 | US7172749 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 02/06/2007 | CA2641659A1 4-acylaminopyridine derivative mediated neurogenesis |
| 02/06/2007 | CA2494199C Bioequivalence test for iron-containing formulations |
| 02/06/2007 | CA2411961C Novel process for the preparation of pyrazolopyrimidinones |
| 02/06/2007 | CA2385755C Prevention of colorectal cancer |
| 02/06/2007 | CA2373291C Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/06/2007 | CA2331672C Dextrin-containing composition for preventing surgical adhesions |
| 02/06/2007 | CA2329543C Fumaric acid microtablets |
| 02/06/2007 | CA2299306C Antimutagenic agents |
| 02/06/2007 | CA2286903C Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment |
| 02/06/2007 | CA2274103C Methods of treating mental diseases, inflammation and pain |
| 02/06/2007 | CA2258662C Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 02/06/2007 | CA2238884C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 02/06/2007 | CA2232152C Bioadhesive solid dosage form |
| 02/06/2007 | CA2214320C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 02/06/2007 | CA2173207C Levobupivacaine and its use as an anaesthetic in patients having or disposed to depressed myocardial contractility |
| 02/06/2007 | CA2132507C Method for altering hair growth and compositions used therefore |
| 02/06/2007 | CA2090967C Water soluble camptothecin analogues, processes and methods |
| 02/05/2007 | CA2518579A1 Method for appetite suppression |
| 02/03/2007 | CA2555410A1 Compositions and methods for enhancing immunity by chemoattractant adjuvants |
| 02/03/2007 | CA2555119A1 New crystalline form iv of agomelatine, process for its preparation and pharmaceutical compositions containing it |
| 02/03/2007 | CA2555117A1 New crystalline form iii of agomelatine, process for its preparation and pharmaceutical compositions containing it |
| 02/03/2007 | CA2555115A1 New crystalline form v of agomelatine, process for its preparation and pharmaceutical compositions containing it |
| 02/01/2007 | WO2008039169A2 Carbohydrate compositions from basidiomycete fungi as biocidal agents active against pathogens |
| 02/01/2007 | WO2007014393A2 Amorphous efavirenz and the production thereof |
| 02/01/2007 | WO2007014352A2 Antiviral phosphonate conjugates for inhibition of hiv |
| 02/01/2007 | WO2007014335A2 Combinations comprising gemcitabine and tyrosine kinase inhibitors for the treatment of pancreatic cancer |
| 02/01/2007 | WO2007014308A1 8-methoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 02/01/2007 | WO2007014285A2 Compositions of polyacids and polyethers and methods for their use as dermal fillers |
| 02/01/2007 | WO2007014273A2 Sulfonamides as selective estrogen receptor modulators |